FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 165

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
CUE Nasdaq Cue Biopharma, Inc. 2834
CYPH Nasdaq Cypherpunk Technologies Inc. 2834
DBVT Nasdaq DBV Technologies S.A. 2834
DCOY Nasdaq Decoy Therapeutics Inc. 2834
DMRA Nasdaq Damora Therapeutics, Inc. 2834
DSNKY Over the counter Daiichi Sankyo Company, Limited 2834
ELAN New York Elanco Animal Health Incorporated 2834
ELTX Nasdaq Elicio Therapeutics, Inc. 2834
ENGN Nasdaq enGene Therapeutics Inc. 2834
EOLS Nasdaq Evolus, Inc. 2834
ETON Nasdaq Eton Pharmaceuticals, Inc. 2834
EVMN New York Evommune, Inc. 2834
EVO Nasdaq Evotec SE 2834
FATE Nasdaq Fate Therapeutics, Inc. 2834
FBRX Nasdaq Forte Biosciences, Inc. 2834
GERN Nasdaq Geron Corporation 2834
GHRS Nasdaq GH Research PLC 2834
GRI Nasdaq GRI Bio, Inc. 2834
GSK New York GSK plc 2834
HELP Nasdaq Cybin Inc. 2834
HIND Nasdaq Vyome Holdings, Inc. 2834
HLN New York Haleon plc 2834
HYPD Nasdaq Hyperion DeFi, Inc. 2834
HYPMY Over the counter Hypera S.A. 2834
IBIO Nasdaq iBio, Inc. 2834
IMMX Nasdaq Immix Biopharma, Inc. 2834
IMRX Nasdaq Immuneering Corporation 2834
IMUX Nasdaq Immunic, Inc. 2834
IMVT Nasdaq Immunovant, Inc. 2834
INCY Nasdaq Incyte Corporation 2834
IPSEY Over the counter Ipsen S.A. 2834
JANX Nasdaq Janux Therapeutics, Inc. 2834
JAZZ Nasdaq Jazz Pharmaceuticals plc 2834
JUNS Nasdaq Jupiter Neurosciences, Inc. 2834
KAPA NYSE American Kairos Pharma, Ltd. 2834
KNSA Nasdaq Kiniksa Pharmaceuticals International, p 2834
KPRX Nasdaq Kiora Pharmaceuticals, Inc. 2834
KROS Nasdaq Keros Therapeutics, Inc. 2834
KRYS Nasdaq Krystal Biotech, Inc. 2834
KYKOY Over the counter Kyowa Kirin Co., Ltd. 2834
LBRX Nasdaq LB Pharmaceuticals Inc 2834
LCTX NYSE American Lineage Cell Therapeutics, Inc. 2834
LGND Nasdaq Ligand Pharmaceuticals Incorporated 2834
LIMN Nasdaq Liminatus Pharma, Inc. 2834
LLY New York Eli Lilly and Company 2834
LONA Nasdaq LeonaBio, Inc. 2834
LPCN Nasdaq Lipocine Inc. 2834
LXEO Nasdaq Lexeo Therapeutics, Inc. 2834
MANE New York Veradermics, Incorporated 2834
MBRX Nasdaq Moleculin Biotech, Inc. 2834
Results 50 through 100 of 165